Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients
CD4+ T cells serve as master regulators of the adaptive immune response to HBV. However, CD4+ T-cell subsets are heterogeneous, and it remains unknown how the antiviral agents affect the different CD4+ T cell subtypes. To this end, the expressions of signature transcription factors and cytokines of...
Saved in:
Main Authors: | Yanhua Zheng, Zemin Huang, Xianhua Chen, Yi Tian, Jun Tang, Yi Zhang, Xiaomin Zhang, Jijun Zhou, Qing Mao, Bing Ni, Qinghong Wang, Yuzhang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/789859 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
by: Young Woon Kim, et al.
Published: (2015-01-01) -
Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study
by: Mengzhi Cai, et al.
Published: (2019-01-01) -
Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy
by: Te-Fu Lin, et al.
Published: (2017-01-01) -
CD4+CD25highCD127low/−FoxP3+ Regulatory T Cell Subpopulations in the Bone Marrow and Peripheral Blood of Children with ALL: Brief Report
by: M. Niedźwiecki, et al.
Published: (2018-01-01) -
Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients
by: Figen Deveci, et al.
Published: (2006-01-01)